Lys134

Site Information
VRLKPTRkFAYLGRL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 38507112
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	lung cancer ( 2 ) , non-small cell lung cancer ( 3 ) , non-small cell squamous cell lung carcinoma ( 3 ) , small-cell lung cancer ( 2 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) [ING5 (human), transfection, infected with GV218-EGFP-ING5 lentivirus construct] ( 1 ) , A549 (pulmonary) ( 1 ) , DMS53 (pulmonary) ( 2 ) , lung ( 2 ) , NCI-H1703 (squamous) ( 3 ) , NCI-H446 (pulmonary) ( 2 ) , NCI-H526 (pulmonary) ( 2 ) , NCI-H69 (pulmonary) ( 2 ) , NCI-H82 (pulmonary) ( 2 )

References
1	Zhang T, et al. (2018) ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation. Oncotarget 9, 1617-1629 29416718 Curated Info
2	Rikova K (2013) CST Curation Set: 20214; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info